Healthcare Sales & Marketing Network News: Orapred ODT

Searching News Database: Orapred ODT

HSMN NewsFeed - 7 Oct 2014
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Sep 2014
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
Devices FDA

HSMN NewsFeed - 30 Dec 2013
Concordia Healthcare Corp. announces filing of Ulesfia(R) with Health Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Dec 2013
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 1 Jun 2006
BioMarin and Alliant Announce FDA Approval of Orapred ODT
Biopharmaceuticals Drug Delivery FDA

Return to NewsFeed

Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 3 additional stories matching:
Orapred ODT
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.